Discovery of potent substrate-type lysine methyltransferase G9a inhibitors for the treatment of sickle cell disease

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development
  • RIKEN
  • Japan Society for the Promotion of Science (23H05473)

This publication has 50 references indexed in Scilit: